Meltzer CJ, Irish J, Angelos P, Busaidy NL, Davies L, Dwojak S et al (2019) American Head and Neck Society Endocrine Section clinical consensus statement: North American quality statements and evidence-based multidisciplinary workflow algorithms for the evaluation and management of thyroid nodules. Head Neck [Internet] 41(4):843–856. https://doi.org/10.1002/hed.25526 (cited 2019 Jun 9)

Article  Google Scholar 

Dean DS, Gharib H (2008) Epidemiology of thyroid nodules. Best Pract Res Clin Endocrinol Metab [Internet] 22(6):901–911. https://doi.org/10.1016/j.beem.2008.09.019

Article  Google Scholar 

Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, Pacini F, Randolph GW, Sawka AM, Schlumberger M, Schuff KG, Sherman SI, Sosa JA, Steward DL, Tuttle RM, Wartofsky L (2016) 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 26(1):1–133. https://doi.org/10.1089/thy.2015.0020 (PMID: 26462967; PMCID: PMC4739132)

Article  Google Scholar 

Durante C, Grani G, Lamartina L, Filetti S, Mandel SJ, Cooper DS (2018) The diagnosis and management of thyroid nodules: a review. JAMA [Internet] [cited 2022 Apr 9] 319(9):914–924. https://jamanetwork.com/journals/jama/fullarticle/2673975

Wu H, Swadley M (2015) The Bethesda system for reporting thyroid cytopathology: into the clinic. Pathol Lab Med Int [Internet] [cited 2019 May 24] 7:47. http://www.dovepress.com/the-bethesda-system-for-reporting-thyroid-cytopathology-into-the-clini-peer-reviewed-article-PLMI

Cibas ES, Ali SZ (2017) The 2017 Bethesda System for Reporting Thyroid Cytopathology. Thyroid 27(11):1341–1346

Article  Google Scholar 

Indrasena BSH (2017) Use of thyroglobulin as a tumour marker. World J Biol Chem 8(1):81

Article  Google Scholar 

Trimboli P, Treglia G, Giovanella L (2014) Preoperative measurement of serum thyroglobulin to predict malignancy in thyroid nodules: a systematic review. Horm Metab Res [Internet]. 47(04):247–252. https://doi.org/10.1055/s-0034-1395517 (cited 2019 Mar 12)

Article  CAS  Google Scholar 

Jo K, Lim DJ (2018) Clinical implications of anti-thyroglobulin antibody measurement before surgery in thyroid cancer. Korean J Intern Med 33(6):1050–1057

Article  CAS  Google Scholar 

Lee EK, Chung K-W, Min HS, Kim TS, Kim TH, Ryu JS, et al (2012) Preoperative serum thyroglobulin as a useful predictive marker to differentiate follicular thyroid cancer from benign nodules in indeterminate nodules. J Korean Med Sci [Internet] [cited 2019 Feb 26] 27(9):1014–8. http://www.ncbi.nlm.nih.gov/pubmed/22969246

Hulikal N, Azhagamuthu RE, Banoth M, Chowhan AK, Yutla M, Sachan A (2020) Can preoperative serum thyroglobulin levels predict the risk of malignancy? Results from prospective analysis of biochemical predictors of malignancy in thyroid nodules. Acta Otorhinolaryngol Ital 40(1):33–37

Article  Google Scholar 

Petric R, Besic H, Besic N (2014) Preoperative serum thyroglobulin concentration as a predictive factor of malignancy in small follicular and Hürthle cell neoplasms of the thyroid gland. World J Surg Oncol 12(1):1–7

Article  Google Scholar 

Petric R, Perhavec A, Gazic B, Besic N (2012) Preoperative serum thyroglobulin concentration is an independent predictive factor of malignancy in follicular neoplasms of the thyroid gland. J Surg Oncol 105(4):351–356

Article  CAS  Google Scholar 

Kars A, Aktan B, Kilic K, Sakat MS, Gözeler MS, Yörük Ö, et al (2018) Preoperative serum thyroglobulin level as a useful predictive marker to differentiate thyroid cancer. ORL J Otorhinolaryngol Relat Spec [Internet] [cited 2022 Aug 15] 80(5–6):290–295. https://pubmed.ncbi.nlm.nih.gov/30253396/

Wang L, Li H, Yang Z, Guo Z, Zhang Q (2015) Preoperative serum thyrotropin to thyroglobulin ratio is effective for thyroid nodule evaluation in euthyroid patients. Otolaryngol Head Neck Surg [Internet] [cited 2022 Aug 15];153(1):15–19. https://pubmed.ncbi.nlm.nih.gov/25883100/

Suh I, Vriens MR, Guerrero MA, Griffin A, Shen WT, Duh Q-Y, et al (2010) Serum thyroglobulin is a poor diagnostic biomarker of malignancy in follicular and Ḧurthle-cell neoplasms of the thyroid. Am J Surg [Internet] [cited 2019 Mar 21]; 200(1):41–46. https://linkinghub.elsevier.com/retrieve/pii/S0002961009007107

Kihara M, Ito Y, Hirokawa M, Masuoka H, Yabuta T, Tomoda C, et al (2011) Role of ultrasonography in patients with cytologically follicular thyroid tumor. Auris Nasus Larynx [Internet] [cited 2019 May 24] 38(4):508–11. http://www.ncbi.nlm.nih.gov/pubmed/21269788

Ahn HS, Kim HJ, Gilbert Welch H (2014) Korea’s thyroid-cancer “Epidemic”—screening and overdiagnosis. N Engl J Med 371(19):1763–1765

Article  Google Scholar 

Miranda-Filho A, Lortet-Tieulent J, Bray F, Cao B, Franceschi S, Vaccarella S, et al (2021) Thyroid cancer incidence trends by histology in 25 countries: a population-based study. Lancet Diabetes Endocrinol [Internet] [cited 2021 Dec 23] 9(4):225–34. http://www.thelancet.com/article/S2213858721000279/fulltext

Mlinarić A, Horvat M, Šupak Smolčić V (2017) Dealing with the positive publication bias: Why you should really publish your negative results. Biochem Med [Internet] [cited 2022 Apr 9] 27(3):030201. https://pubmed.ncbi.nlm.nih.gov/29180912/